$0.5472
10.65%
Downside
Day's Volatility :14.61%
Upside
4.43%
38.18%
Downside
52 Weeks Volatility :74.24%
Upside
58.33%
Period | Catheter Precision Inc | Index (Russel 2000) |
---|---|---|
3 Months | 38.31% | 0.0% |
6 Months | 38.01% | 0.0% |
1 Year | 5.81% | 0.0% |
3 Years | 5.81% | -20.1% |
Market Capitalization | 3.7M |
Book Value | $3.12 |
Earnings Per Share (EPS) | -12.18 |
Wall Street Target Price | 7.0 |
Profit Margin | 0.0% |
Operating Margin TTM | -2052.63% |
Return On Assets TTM | -56.36% |
Return On Equity TTM | -454.15% |
Revenue TTM | 314.0K |
Revenue Per Share TTM | 0.07 |
Quarterly Revenue Growth YOY | 844.4000000000001% |
Gross Profit TTM | 0.0 |
EBITDA | -21.3M |
Diluted Eps TTM | -12.18 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | 0.0 |
EPS Estimate Next Year | 0.0 |
EPS Estimate Current Quarter | 0.0 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 1179.24%
Sell
Neutral
Buy
Catheter Precision Inc is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Catheter Precision Inc | 29.33% | 38.01% | 5.81% | 5.81% | 5.81% |
Stryker Corporation | 0.86% | 12.4% | 15.49% | 28.53% | 77.74% |
Boston Scientific Corp. | 11.25% | 36.51% | 40.96% | 76.8% | 100.56% |
Edwards Lifesciences Corp. | 3.89% | 34.72% | 1.32% | -5.35% | 56.97% |
Abbott Laboratories | -3.84% | 0.25% | -4.89% | -12.22% | 35.01% |
Medtronic Plc | 5.71% | 8.68% | -4.84% | -33.51% | -4.04% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Catheter Precision Inc | NA | NA | NA | 0.0 | -4.54 | -0.56 | NA | 3.12 |
Stryker Corporation | 37.6 | 37.6 | 2.92 | 11.96 | 0.19 | 0.07 | 0.01 | 50.33 |
Boston Scientific Corp. | 63.33 | 63.33 | 1.8 | 2.33 | 0.09 | 0.05 | NA | 13.56 |
Edwards Lifesciences Corp. | 38.77 | 38.77 | 5.19 | 2.76 | 0.21 | 0.12 | NA | 11.82 |
Abbott Laboratories | 32.15 | 32.15 | 5.99 | 4.63 | 0.15 | 0.06 | 0.02 | 22.31 |
Medtronic Plc | 26.83 | 26.83 | 1.52 | 5.2 | 0.08 | 0.04 | 0.03 | 38.95 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Catheter Precision Inc | Buy | $3.7M | 5.81% | NA | 0.0% |
Stryker Corporation | Buy | $125.6B | 77.74% | 37.6 | 16.03% |
Boston Scientific Corp. | Buy | $110.8B | 100.56% | 63.33 | 12.05% |
Edwards Lifesciences Corp. | Buy | $54.4B | 56.97% | 38.77 | 23.01% |
Abbott Laboratories | Buy | $179.5B | 35.01% | 32.15 | 13.96% |
Medtronic Plc | Buy | $112.2B | -4.04% | 26.83 | 13.0% |
advanced excimer laser-based vascular and dermatological therapies we are a commercial-stage medical device company leveraging our advanced excimer laser-based platform for use in the treatment of vascular and dermatological diseases. we believe our products enhance patients’ quality of life by restoring blood-flow in arteries and clearing chronic skin conditions. we currently manufacture and market two lines of products: dabra catheter and laser is cleared by the u.s. fda as a tool for the minimally invasive endovascular treatment of vascular blockages resulting from lower extremity vascular disease, which includes peripheral artery disease (pad), which commonly occurs in the legs. pharos excimer laser pharos is designed for use in the treatment of inflammatory skin conditions and is fda cleared as a tool used in the treatment of psoriasis, atopic dermatitis, and leukoderma. our goal is to become the leading medical device company marketing excimer lasers as tools for the treatment of
Organization | Catheter Precision Inc |
Employees | 14 |
CEO | Mr. David A. Jenkins |
Industry | Miscellaneous |
A Spac I Acquisition Corp
$0.55
-4.92%
Keyarch Acquisition Corp
$0.55
-4.92%
Connexa Sports Technologies Inc
$0.55
-4.92%
Us Value Etf
$0.55
-4.92%
First Wave Biopharma Inc
$0.55
-4.92%
Global X Msci Next Emerging
$0.55
-4.92%
Fat Projects Acquisition Corp
$0.55
-4.92%
Ishares Intl Div Growth Etf
$0.55
-4.92%
Corsair Gaming, Inc.
$0.55
-4.92%